GrowingWithAK
← Back

Tata Mutual Fund · #135812

Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option

Equity · Sectoral/ Thematic · Regular · Growth

Regular TER: 2.41% · as of

5-year NAV · change the window using the controls in the rolling-returns card below ↓

2021-10-25 → 2026-10-21

min ₹15.00 change +78.0% max ₹34.00

Latest NAV

₹30.5440

as of 2026-10-21 · -1.23% vs 2026-10-19

Earliest NAV in archive

2015-12-29

AMFI archive begins Apr 2006

Worst peak-to-trough drawdown

-21.94%

trough 2018-06-05 (since archive start)

Trailing CAGR vs assigned benchmark

Window Scheme CAGR Benchmark CAGR Excess Period
1y -1.83% — — 2025-10-23 → today · 1.0y
3y +15.62% — — 2023-10-23 → today · 3.0y
5y +12.14% — — 2021-10-22 → today · 5.0y
10y +12.34% — — 2016-10-21 → today · 10.0y

Benchmark assignment is mapped by category and sub-category from public sources. "Since inception (in archive)" uses the earliest NAV in the AMFI archive (April 2006 onward).

Rolling 1-year returns distribution · 1229 daily entry points · last 5 years

Imagine buying this fund on any day in this period and holding for exactly one year. Each bar counts how often that ended with a given return: green bars made money, red bars lost money even after a full year. Taller bar = more common outcome.

0% -12.1% to -9.7%: 26 windows -9.7% to -7.2%: 71 windows -7.2% to -4.8%: 57 windows -4.8% to -2.4%: 78 windows -2.4% to +0.1%: 100 windows +0.1% to +2.5%: 47 windows +2.5% to +5.0%: 48 windows +5.0% to +7.4%: 74 windows +7.4% to +9.8%: 78 windows +9.8% to +12.3%: 67 windows +12.3% to +14.7%: 61 windows +14.7% to +17.2%: 83 windows +17.2% to +19.6%: 43 windows +19.6% to +22.0%: 32 windows +22.0% to +24.5%: 47 windows +24.5% to +26.9%: 17 windows +26.9% to +29.3%: 30 windows +29.3% to +31.8%: 10 windows +31.8% to +34.2%: 5 windows +34.2% to +36.7%: 6 windows +36.7% to +39.1%: 14 windows +39.1% to +41.5%: 32 windows +41.5% to +44.0%: 15 windows +44.0% to +46.4%: 23 windows +46.4% to +48.8%: 29 windows +48.8% to +51.3%: 20 windows +51.3% to +53.7%: 38 windows +53.7% to +56.2%: 36 windows +56.2% to +58.6%: 24 windows +58.6% to +61.0%: 18 windows -12% +61%

Median 1y return

+11.1%

Mean 1y return

+15.9%

Best / worst 1y

+61.0% / -12.1%

Windows positive

73%

5th %ile -8.4%
25th %ile -0.5%
75th %ile +25.6%
95th %ile +54.9%

Longer rolling windows · annualised

Same idea over longer holding periods. Returns are CAGR (annualised) so they're directly comparable to the trailing-CAGR table above.

Period Median Mean Worst Best % positive Windows
3y rolling +19.4% +16.4% -5.2% +28.4% 88% 1925
5y rolling +14.9% +17.0% +7.5% +29.6% 100% 1433
10y rolling +12.7% +12.5% +10.8% +13.6% 100% 202

Beat-benchmark consistency · vs assigned benchmark, across overlapping windows

Of all the rolling windows we observed, how often did this fund's return exceed the benchmark's over the same window. A higher fraction means more consistent outperformance, but says nothing about future windows.

Period Windows beat Total windows % beat Avg excess
(annualised)
1y rolling 197 590 33% -1.3%
3y rolling 0 99 0% -1.2%

Monthly returns · since inception (Dec 2015)

How each calendar month went: green months gained, red months lost. Deeper colour = bigger move.

Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Year
2026 -5.5 +5.2 -6.4 +6.9 +4.0 +3.5 +4.2 +0.5 -4.5 -5.6 · · +1.1
2025 -7.7 -9.4 +7.8 +2.5 -0.4 +3.3 +3.4 -2.6 -1.3 +2.4 +0.6 -2.2 -4.9
2024 +6.1 +4.4 -0.1 +0.5 -0.6 +4.8 +10.3 +7.0 +0.8 -1.4 -0.7 +4.2 +40.4
2023 -1.7 -3.8 +1.3 +3.9 +2.7 +8.0 +8.2 +0.3 +2.4 -3.7 +11.6 +3.7 +36.6
2022 -6.3 -3.0 +4.8 -2.0 -5.8 -2.9 +6.0 -0.3 +2.4 +2.7 +0.4 -3.5 -8.0
2021 -4.2 -1.1 +2.7 +8.7 +3.4 +3.9 +3.0 +2.9 -2.2 -4.1 +2.4 +2.7 +19.1
2020 +4.4 +0.1 -7.2 +21.4 +2.5 +0.5 +11.5 +0.9 +8.2 -1.5 +5.4 +7.2 +64.4
2019 +0.0 -1.6 +5.8 +1.5 -5.2 -0.9 +1.5 -0.0 +0.3 +3.3 +2.5 -1.4 +5.5
2018 +0.2 -3.0 -4.1 +7.1 -9.5 +5.6 +3.0 +10.6 -6.3 -1.7 -1.3 -1.4 -2.6
2017 +0.6 +4.7 +1.1 +1.2 -8.4 +3.1 +0.4 -8.1 +1.7 +5.8 +0.2 +3.3 +4.7
2016 +0.8 -5.6 -1.8 +1.5 -3.1 +1.4 +7.1 -4.5 -0.3 -0.4 -2.5 -7.5 -14.7
Avg -1.2 -1.2 +0.4 +4.8 -1.9 +2.8 +5.3 +0.6 +0.1 +0.1 +1.9 +0.5 +14.0

All values in %. Each cell compares the last NAV of the month with the last NAV of the month before. The latest month is month-to-date; the Year column compounds the months shown on that row. The Avg row is the plain average of each column across the years shown (10 complete calendar years in the last column); the running month is left out of it.

Portfolio mix · asset class breakdown as of 2026-09-30

Equity 96.8%
Debt 1.1%
Other / unclassified 2.0%
Equity split: Large 26.0% Mid 33.9% Small 37.0%

Size axis (Style Box) · Large / Mid / Small split of latest disclosed holdings

Per AMFI's semi-annual Categorisation of Stocks (top 100 = Large, 101-250 = Mid, 251+ = Small).

  • Large Cap 26.0%
  • Mid Cap 33.9%
  • Small Cap 37.0%
  • Cash & Equivalents 0.3%
  • Unlisted & other equity 2.9%

Index overlap

· vs · share of this fund's AUM that sits in stocks the index also includes

No holdings data yet for this fund.

Top stocks held · 42 holdings as of 2026-09-30 See changes vs previous snapshot →

Stock Sector % of fund
SUN PHARMACEUTICAL INDUSTRIES LTD Pharmaceuticals & Biotechnology 7.99%
ABBOTT INDIA LTD Pharmaceuticals & Biotechnology 5.94%
HEALTHCARE GLOBAL ENTERPRISES LTD Healthcare Services 5.92%
DIVI LABORATORIES LTD Pharmaceuticals & Biotechnology 5.68%
DR REDDYS LABORATORIES LTD Pharmaceuticals & Biotechnology 4.65%
APOLLO HOSPITALS ENTERPRISE LTD Healthcare Services 4.36%
RAINBOW CHILDRENS MEDICARE LTD Healthcare Services 4.30%
CIPLA LTD Pharmaceuticals & Biotechnology 4.22%
TORRENT PHARMACEUTICALS LTD Pharmaceuticals & Biotechnology 3.76%
MAX HEALTHCARE INSTITUTE LTD Healthcare Services 3.71%
LUPIN LTD Pharmaceuticals & Biotechnology 3.14%
BAYER CROPSCIENCE LTD Fertilizers & Agrochemicals 2.96%
SYNGENE INTERNATIONAL LTD Healthcare Services 2.85%
PROCTER & GAMBLE HEALTH LTD Pharmaceuticals & Biotechnology 2.75%
SAI LIFE SCIENCES LTD Pharmaceuticals & Biotechnology 2.60%
PI INDUSTRIES LTD Fertilizers & Agrochemicals 2.59%
ANTHEM BIOSCIENCES LTD Pharmaceuticals & Biotechnology 2.57%
PFIZER LTD Pharmaceuticals & Biotechnology 2.50%
ALKEM LABORATORIES LTD Pharmaceuticals & Biotechnology 2.36%
FDC LTD Pharmaceuticals & Biotechnology 2.24%

Sector mix

Healthcare: 89.2% Chemicals: 9.5% Fast Moving Consumer Goods: 1.2%
  • Healthcare 89.2%
  • Chemicals 9.5%
  • Fast Moving Consumer Goods 1.2%

Risk metrics, trailing 3y (733 matched daily returns, 2023-10-25 → 2026-10-21)

Sharpe

+0.74

excess return per unit of total volatility

Sortino

+1.05

excess return per unit of downside vol

Calmar

+0.92

CAGR / |max DD| in window

Beta vs benchmark

+0.83

scheme sensitivity to benchmark moves

Tracking error

+5.72%

annualised stdev of (scheme − benchmark)

Up capture

+82.2%

% of benchmark gain captured on up days

Down capture

+81.1%

% of benchmark loss participated in

Risk-free rate assumed 6.0% annualised. Benchmark = Nifty Healthcare Index (assigned by category mapping).

Factual data only. No investment advice or recommendation. Read the scheme document and consult a SEBI-registered Investment Adviser for personalised guidance.